Zimmer Biomet Holdings, Inc.
ZBH
Rank in Stocks
#1249
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing... Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
Share Price
$95.07
Last synced: 2026-10-19
Market Cap
$18.13B
Change (1 day)
0.21%
Change (1 year)
-7.47%
Country
US
Trade Zimmer Biomet Holdings, Inc. (ZBH)
Category
Healthcare
Earnings for Zimmer Biomet Holdings, Inc. (ZBH)
Earnings in Jun 2026 TTM: $933.60M
According to Zimmer Biomet Holdings, Inc. latest financial reports the company's current earnings are $933.60M. In 2024 the company made an earning of $1.04B, a decrease compared to its 2023 earnings that were of $1.07B. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Zimmer Biomet Holdings, Inc. from 2000 to 2026
Earnings at the end of each year
| Year | Earnings | Change |
|---|---|---|
| 2026 (TTM) | $933.60M | 12.37% |
| 2025 | $830.80M | -19.85% |
| 2024 | $1.04B | -2.88% |
| 2023 | $1.07B | 164.51% |
| 2022 | $403.50M | -19.14% |
| 2021 | $499.00M | -574.33% |
| 2020 | $-105.20M | -111.61% |
| 2019 | $905.80M | -434.12% |
| 2018 | $-271.10M | -158.35% |
| 2017 | $464.60M | 16.27% |
| 2016 | $399.60M | 160.84% |
| 2015 | $153.20M | -83.69% |
| 2014 | $939.40M | -4.25% |
| 2013 | $981.10M | -0.91% |
| 2012 | $990.10M | 1.14% |
| 2011 | $978.90M | 13.80% |
| 2010 | $860.20M | -13.82% |
| 2009 | $998.20M | -11.02% |
| 2008 | $1.12B | -0.87% |
| 2007 | $1.13B | -3.20% |
| 2006 | $1.17B | 12.33% |
| 2005 | $1.04B | 42.27% |
| 2004 | $731.50M | 67.20% |
| 2003 | $437.50M | 12.50% |
| 2002 | $388.90M | 61.44% |
| 2001 | $240.90M | -10.11% |
| 2000 | $268.00M | 0.00% |
Earnings for similar companies or competitors
| Company | Earnings | Earnings Difference | Country |
|---|---|---|---|
| $7.51B | 704.52% |
US
|
|
| $5.56B | 495.87% |
IE
|
|
| $5.15B | 451.41% |
US
|
|
| $3.86B | 313.56% |
US
|
|
| - | - |
DE
|
